Urinary Microbiome Differences in Bladder Cancer, Benign Urinary Diseases and Healthy Counterparts in Adult Male Population

ConditionBladder Cancer

Trial statusRecruiting

Trial phaseNot listed

Trial typeObservational

Biological sexMale

Age50-70

SponsorRegina Elena Cancer Institute

About this trial

The study aims to investigate alterations in the bladder microbiome in adult men with bladder cancer, healthy men, and men with benign urinary disease

Eligibility criteria

Qualifiers

Diagnosis of bladder cancer

Negative urine culture

Histological confirmation of urothelial carcinoma

Patients undergoing radical cystectomy

Disqualifiers

Presence of other neoplasias

History of previous BCG therapy

Use of indwelling catheter

Active antibiotic treatment with two months prior to participation

Trial design

Treatments tested in this trial

Investigating differences in the bladder microbiome

Treatment groups

50 Participants

are divided into 3 treatment groups

Sponsors and collaborators

Regina Elena Cancer Institute

Lead sponsor

Source ClinicalTrials.gov